Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant human FSH-CTP fusion protein

recombinant human follicle-stimulating hormone-CTP fusion protein · Changchun GeneScience Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant human FSH-CTP fusion protein, covering 2024-08-20 to 2024-08-20. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection [Phase 3]

See pricing